NCT06147466

Time Spent In Target Glucose Range in Women With T2D Diabetes in Pregnancy

Time Spent In the Target Glucose Range and MatErnaL and Neonatal Effects in Women With tYpe 2 Diabetes in Pregnancy (TIMELY)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Mount Sinai Hospital, Canada · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Prospective cohort study to determine to what extent women with type 2 diabetes are achieving the time in the target range outlined for women with type 1 diabetes (70-140 mg/dl or 3.5-7.8 mmol/l), overall and by trimester, by standard CGM measures and functional data analysis

Conditions

• Diabete Type 2
• Pregnancy in Diabetic

Interventions

Type	Name	Description
DEVICE	Dexcom Continuous Glucose Monitoring	A continuous glucose monitor (CGM) is a wearable device that tracks blood glucose (sugar) every few minutes, throughout the day and night. The readings are relayed in real time to a device which can be read by the patient, caregiver or health-care provider, even remotely

Timeline

• Start date: 2023-03-01
• Primary completion: 2026-03-01
• Completion: 2026-06-01
• First posted: 2023-11-27
• Last updated: 2024-03-20

Locations

1 site across 1 country: Canada

Regulatory

• FDA-regulated device study